Skip to main content

Biomaterials Market to Develop at Phenomenal 15.4% CAGR by 2031 | SkyQuest Technology

Westford, USA, Aug. 27, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Biomaterials market will attain a value of USD 438.1 billion by 2031, with a CAGR of 15.4% over the forecast period (2024-2031). Growing investments in the development of novel biomaterials and high demand for advanced wound care products are predicted to bolster the demand for biomaterials over the coming years. Rising demand for regenerative medicine is also projected to create new business scope for biomaterials suppliers across the forecast period.

Download a detailed overview:

https://www.skyquestt.com/sample-request/biomaterials-market

Browse in-depth TOC on “Biomaterials Market”

  • Pages – 197
  • Tables – 95
  • Figures – 76

Biomaterials Market Overview:

Report CoverageDetails
Market Revenue in 2023$ 155.9 billion
Estimated Value by 2031$ 438.1 billion
Growth RatePoised to grow at a CAGR of 15.4%
Forecast Period2024–2031
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredType, Application, and Region
Geographies CoveredNorth America, Europe, Asia Pacific, and the Rest of the world
Report HighlightsUpdated financial information / product portfolio of players
Key Market OpportunitiesGrowing demand for regenerative medicine
Key Market DriversAdvancements in wound care and rising investments in the development of smart biomaterials

Metallic Biomaterials Hold Sway Over Revenue Generation Owing to High Use in Prosthetics

The growing incidence of trauma and injuries worldwide has resulted in high demand for prosthetics. Metallic biomaterials are rigid and offer excellent support to medical prosthetics and implants while also being necessarily flexible. This is why metallic biomaterials are being extensively used in the making of dental implants and other types of medical prosthetics.

Biomaterials are Projected to be Extensively Used in Cardiovascular Applications as their Incidence Rises

Poor lifestyle choices have led to a massive upsurge in the incidence of cardiovascular diseases thereby promoting the use of biomaterials. The use of biomaterials helps in repairing and regenerating cardiovascular tissues to cure patients. Growing investments in the development of novel cardiovascular treatments are helping this segment maintain a high market share.

Heavy Investments on Medical R&D Helping North America Dominate Biomaterials Demand

North America is estimated to emerge as the leading market for biomaterials providers owing to high investments in healthcare research. Growing incidence of cardiovascular disorders and the rising use of biomaterials in healthcare 3D printing are also helping this region hold the leading position. The United States and Canada are slated to be the top countries for biomaterials companies in this region.

Request Free Customization of this report:

https://www.skyquestt.com/speak-with-analyst/biomaterials-market

Biomaterials Market Insights:

Drivers

  • Increasing demand for novel treatments
  • Rising investments in the development of new biomaterials
  • Use of biomaterials in healthcare 3D printing applications

Restraints

  • High costs of biomaterials
  • Issues regarding biocompatibility of biomaterials
  • Ethical concerns regarding the use of biomaterials

Prominent Players in Biomaterials Market

The following are the Top Bioinformatics Companies

  • Evonik Industries AG
  • Corbion
  • BASF SE
  • Royal DSM NV
  • Invibio Ltd.
  • Carpenter Technology Corporation
  • Celanese Corporation
  • Berkeley Advanced Biomaterials Inc.
  • Cam Bioceramics B.V.
  • Collagen Matrix Inc.

View report summary and Table of Contents (TOC):

https://www.skyquestt.com/report/biomaterials-market

Key Questions Answered in Biomaterials Market Report

  • What drives the global Biomaterials market growth?
  • Who are the leading Biomaterials providers in the world?
  • Which region leads the demand for Biomaterials in the world?

This report provides the following insights:

  • Analysis of key drivers (growing demand for novel treatments of chronic diseases, high use of biomaterials in healthcare 3D printing), restraints (high costs of biomaterial development, biocompatibility issues of biomaterials, ethical concerns regarding use of biomaterials), and opportunities (high demand for regenerative medicine, development of advanced wound care solutions), influencing the growth of Biomaterials market.
  • Market Penetration: All-inclusive analysis of product portfolio of different market players and status of new product launches.
  • Product Development/Innovation: Elaborate assessment of R&D activities, new product development, and upcoming trends of the Biomaterials market.
  • Market Development: Detailed analysis of potential regions where the market has potential to grow.
  • Market Diversification: Comprehensive assessment of new product launches, recent developments, and emerging regional markets.
  • Competitive Landscape: Detailed analysis of growth strategies, revenue analysis, and product innovation by new and established market players.

Related Reports:

Biomarkers Market

Bioplastics Market

Biosimilars Market

Biosensors Market

Bioinformatics Market

About Us:
SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:
Mr. Jagraj Singh
Skyquest Technology
1 Apache Way, 
Westford, 
Massachusetts 01886
USA (+1) 617-230-0741
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.